首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1365篇
  免费   57篇
林业   109篇
农学   24篇
基础科学   7篇
  156篇
综合类   250篇
农作物   28篇
水产渔业   72篇
畜牧兽医   712篇
园艺   14篇
植物保护   50篇
  2020年   13篇
  2019年   14篇
  2018年   16篇
  2016年   17篇
  2015年   15篇
  2014年   21篇
  2013年   41篇
  2012年   44篇
  2011年   59篇
  2010年   28篇
  2009年   25篇
  2008年   54篇
  2007年   39篇
  2006年   50篇
  2005年   43篇
  2004年   43篇
  2003年   41篇
  2002年   40篇
  2001年   39篇
  2000年   33篇
  1999年   32篇
  1998年   14篇
  1996年   11篇
  1995年   9篇
  1994年   12篇
  1993年   16篇
  1992年   39篇
  1991年   34篇
  1990年   30篇
  1989年   31篇
  1988年   33篇
  1987年   31篇
  1986年   23篇
  1985年   25篇
  1984年   21篇
  1983年   19篇
  1982年   19篇
  1981年   11篇
  1979年   10篇
  1978年   9篇
  1977年   10篇
  1976年   11篇
  1974年   11篇
  1973年   12篇
  1972年   13篇
  1971年   10篇
  1970年   9篇
  1969年   16篇
  1967年   11篇
  1867年   9篇
排序方式: 共有1422条查询结果,搜索用时 15 毫秒
41.
The objective of this research was to evaluate the efficacy of two antimicrobials (ampicillin and ceftiofur), a modified-live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine, and low dose exposure to Streptococcus suis on disease associated with PRRSV/S. suis coinfection. Fifty-six, crossbred, PRRSV-free pigs were weaned at 10-12 days of age and randomly assigned to five treatment groups. All pigs were inoculated with 2ml of 10(6.4) TCID50/ml of high virulence PRRSV isolate VR-2385 intranasally at 29-31 days of age (day 0 of the study) followed 7 days later by intranasal inoculation with 2ml of 10(8.9)colony forming units(CFU)/ml S. suis type 2 isolate ISU VDL #40634/94. Pigs in group 1 (n=10) served as untreated infected positive controls. Pigs in group 2 (n=12) were treated with 5.0 mg/kg ceftiofur hydrochloride intramuscularly (IM) on days 8, 11, and 14. Pigs in group 3 (n=11) were treated with 11 mg/kg ampicillin IM on days 8-10. Pigs in group 4 (n=12) were vaccinated 14 days prior to PRRSV challenge with a commercial modified-live PRRSV vaccine. Pigs in group 5 (n=11) were exposed to a 1:100 dilution of the S. suis challenge inoculum 19 days prior to S. suis challenge. Mortality was 80, 25, 82, 83, and 36% in groups 1-5, respectively. The reduced dose S. suis exposure had some residual virulence, evidenced by S. suis induced meningitis in two pigs after exposure. Treatment with ceftiofur hydrochloride and reduced dose exposure to S. suis were the only treatments which significantly (P<0.05) reduced mortality associated with PRRSV/S. suis coinfection, significantly (P<0.05) reduced recovery of S. suis from tissues at necropsy, and significantly (P<0.05) reduced the severity of gross lung lesions.  相似文献   
42.
Molecular and biological characterisation of Cryptosporidium in pigs   总被引:1,自引:0,他引:1  
OBJECTIVE: Genetic and biological characterisation of 12 isolates of Cryptosporidium from pigs and comparing them with Cryptosporidium isolates from humans and cattle. DESIGN: Cryptosporidium isolates from pigs were compared with those obtained from human and cattle using rDNA sequence analysis. The infectivity of two of the porcine isolates was determined in neonatal mice and the clinical history of the infected pigs recorded. RESULTS: Pig-derived isolates of Cryptosporidium exhibited two distinct genotypes; a porcine genotype and a bovine genotype, which is common to cattle and other livestock. The porcine genotype did not produce any infection in neonatal mice whereas the bovine genotype did. CONCLUSION: Two distinct genetically and biologically differing strains of Cryptosporidium appeared to be associated with acute diarrhoea in pigs. Whether Cryptosporidium was a primary or secondary pathogen is unclear but warrants further investigation. As the bovine genotype is known to infect humans, the results suggest that pigs can act as reservoirs of cryptosporidial infections for humans and other live-stock. The zoonotic potential of the pig-adapted genotype is uncertain and requires further study.  相似文献   
43.
44.
45.
46.
47.
48.
49.
50.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号